Cell Therapy Next Current Issue

The following articles appeared in the print edition of Cell Therapy Next.

Table of Contents

• Multiple myeloma: The next frontier for cell therapy Drew Amorosi
• A Phase I Clinical Trial of T Cells Expressing a Novel Fully Human Anti-BCMA CAR for Treating Multiple Myeloma Drew Amorosi
• A Safety and Efficacy Study Evaluating CTX120 in Subjects with Relapsed or Refractory Multiple Myeloma Drew Amorosi
• Autologous CD8+ T cells Expressing an Anti-BCMA CAR in Patients with Myeloma Drew Amorosi
• BCMA-Specific CAR T Cells Combined with a Gamma Secretase Inhibitor (JSMD194) to Treat Relapsed or Persistent Multiple Myeloma Drew Amorosi
• First-In-Human Study of REGN5459 in Patients With Relapsed or Refractory Multiple Myeloma Drew Amorosi
• Upfront CART-BCMA with or without huCART19 in High-risk Multiple Myeloma Drew Amorosi
• Natural Killer Cells Plus Immunotherapy for Triple-Negative Breast Cancer Drew Amorosi
• Bristol-Myers Squibb Seeks FDA Biologics License for CAR T-cell Therapy in Advanced Large B-cell Lymphoma
• FDA Clears IND Application for Natural Killer Cell Therapy for Glioblastoma Multiforme
• Orphan Drug Designation Granted to Multigenic CAR-T for AML
• Rare Pediatric Disease Designation Given to Gene Therapy for Sickle Cell Disease
• Guide Catheter for Cardiac Cell Therapy Delivery Cleared
• Kite submits BLA to FDA for CAR T-cell therapy in mantle cell lymphoma
• Expert Panel Document Guides CAR-T Use for Advanced B-Cell Lymphoma Drew Amorosi
• Actinium Partners with UC Davis on Gene Therapy for HIV-related Lymphoma
• Astellas, Adaptimmune Partner to Develop Off-the-Shelf CAR-T and T-cell Therapies
• Cytovia Partners with UCSF, New York Stem Cell Foundation to Develop Novel CAR-NK Cell Therapies
• Patient-derived Stem Cell Therapy Trial for Geographic Atrophy Launches
• Stem Cell Therapy for ACLF Progresses to Safety, Efficacy Trial